The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: Earnings Drive Mixed UK Stocks, As BOE Stands Pat

Wed, 22nd Oct 2014 09:49

LONDON (Alliance News) - UK stocks are putting in a mixed performance Wednesday, with company earnings driving the main stock movers.

Meanwhile, the pound has fallen heavily against other major major currencies after the minutes of the Bank of England's latest monetary policy meeting showed increasing concern amongst rate setters over a slowdown in global growth, particularly in the eurozone.

By mid-morning Wednesday the FTSE 100 is down 0.2% at 6,361.48, while the FTSE 250 is up 0.5% at 15,098.77, and the AIM All-Share is up 0.3% at 706.98.

Major European markets are also mixed, with the French CAC 40 down 0.1%, and the German DAX 30 down 0.2%.

The minutes of the October Monetary Policy Committee meeting earlier this month showed that rate setters for the Bank of England voted 7-2 to keep the UK's base interest rate on hold at 0.5%, in line with expectations. The two members voting for a rate hike were Martin Weale and Ian McCafferty. The MPC members voted unanimously to maintain the BoE's stock of purchased assets at GBP375 billion, also in line with expectations.

There had been very little expectation of a shift in the voting pattern from the September minutes. There has been little reason to turn more hawkish over the last month, given the slowdown in eurozone growth and a pick up in market volatility, but it also seemed unlikely that Weale and McCafferty would retract their votes for a rate hike just one month after sticking their necks out on the issue.

While the vote was therefore in line with expectations, the minutes have been taken as doveish due to the increased concern evident among that rate setters about the global growth slowdown, particularly in the eurozone, and the damaging effect it could have on the UK economy.

"Once again, the news on global activity and inflation had, on balance, been modestly to the downside, particularly in the euro area," the minutes read. "There were increasing indications that the slight slowing in the pace of (UK) expansion towards the end of the year that the Committee had been expecting for some time would indeed occur."

The effect of the cautious tone was felt in the pound, which has fallen to a four-day low against the dollar of USD1.6010. Against the euro the pound also slipped, despite the euro remaining under pressure amid reports of the European Central Bank discussing bond buying in an effort to boost the region's slowing growth. Currently the pound buys EUR1.2630.

The euro, the European banking system, and the wider economy are in focus ahead of the weekend when the results of stress tests on banks within the eurozone are due. According to a report from the Spanish news agency Efe, at least 11 banks of the 130 being tested are set to fail the tests. An ECB spokesperson has since said that the Efe report is entirely speculative at this stage.

On the London equities market, British American Tobacco is the worst FTSE 100 performer, down 4.2% after saying that its profitability has been hit by the relative strength of the pound. The cigarette maker said its nine-month revenue was up 2.4% at constant exchange rates but down 9.6% at actual rates. Imperial Tobacco has followed a little lower, down 0.9%.

The motor insurers Direct Line and Admiral are the best blue chip performers, up 2.7% and 2.5%, respectively, following a report from the AA that said insurance premiums have risen by 1.2% over the three months to September 30, which is reportedly the first rise in premiums in more than two years.

FTSE 250-listed Playtech is the best performer in the index, up 5.8% after reporting faster that expected revenue growth, particularly in Asia, where revenue for the gaming group was up 85%, after being up 72% in the first half.

International Personal Finance is up 4.4% after reporting a 5% rise in pretax profit in the third quarter to GBP34.0 million, up from GBP32.5 million a year earlier. Revenue rose to GBP245.5 million from GBP264.4 million, helped by a 4.8% increase in customer numbers to 2.6 million.

SuperGroup is the worst performing FTSE 250 listing. The fashion retailer said it has appointed Non-Executive Director Euan Sutherland as its new chief executive, with founder Julian Dunkerton moving to the newly created role of founder and product and brand director, a move the company said would assist an accelerated expansion overseas. Analyst also have trimmed full-year estimates for the company due to the warm UK weather that has hit the clothing retail sector in general.

Still to come Wednesday, GlaxoSmithKline is due to report third quarter numbers at midday, with the market expectant to hear of any financial detail around the development of a vaccine against Ebola, after the company said it is working at an "unprecedented rate" on the issue.

US consumer price inflation at 1330 BST will be of keen interest given the heightened concerns over the strength of the economy as monetary stimulus is withdrawn. The expectation is for a slight fall in CPI to 1.6% year-on-year in September, from 1.7% in August. The US, like the UK, targets 2.0% inflation, and anything greater than the expected 0.1-percentage-point fall will likely cause some concern, analysts say.

US third quarter earnings season is in full flow, with a raft of numbers due Wednesday, including from AT&T Inc and Boeing Company.

Futures currently indicate that Wall Street will follow European markets to a mixed open, with the DJIA and the S&P 500 pointing down 0.1%, but the Nasdaq Composite up 0.1%.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.